|
|
||||||||||||||
|
|
|||||||||||||||
ASTHMA |
1 Department of Pediatrics, University of Padova, Italy
2 Department of Pediatrics, University of Verona, Italy
3 Department of Clinical Medicine, Nephrology and Health Sciences, University of Parma, Italy
Correspondence to:
Correspondence to:
Dr Eugenio Baraldi, Department of Pediatrics, Via Giustiniani 3, 35128 Padova, Italy;
eugi{at}pediatria.unipd.it
Background: Cysteinyl leukotrienes (Cys-LTs) and isoprostanes are inflammatory metabolites derived from arachidonic acid whose levels are increased in the airways of asthmatic patients. Isoprostanes are relatively stable and specific for lipid peroxidation, which makes them potentially reliable biomarkers for oxidative stress. A study was undertaken to evaluate the effect of a course of oral steroids on Cys-LT and 8-isoprostane levels in exhaled breath condensate of children with an asthma exacerbation.
Methods: Exhaled breath condensate was collected and fractional exhaled nitric oxide (FENO) and spirometric parameters were measured before and after a 5 day course of oral prednisone (1 mg/kg/day) in 15 asthmatic children with an asthma exacerbation. Cys-LT and 8-isoprostane concentrations were measured using an enzyme immunoassay. FENO was measured using a chemiluminescence analyser. Exhaled breath condensate was also collected from 10 healthy children.
Results: Before prednisone treatment both Cys-LT and 8-isoprostane concentrations were higher in asthmatic subjects (Cys-LTs, 12.7 pg/ml (IQR 5.415.6); 8-isoprostane, 12.0 pg/ml (9.429.5)) than in healthy children (Cys-LTs, 4.3 pg/ml (2.05.7), p=0.002; 8-isoprostane, 2.6 pg/ml (2.13.0), p<0.001). After prednisone treatment there was a significant decrease in both Cys-LT (5.2 pg/ml (3.98.8), p=0.005) and 8-isoprostane (8.4 pg/ml (5.411.6), p=0.04) concentrations, but 8-isoprostane levels remained higher than in controls (p<0.001). FENO levels, which fell significantly after prednisone treatment (p<0.001), did not correlate significantly with either Cys-LT or 8-isoprostane concentrations.
Conclusion: After a 5 day course of oral prednisone there is a reduction in Cys-LT and 8-isoprostane levels in EBC of children with an asthma exacerbation, although 8-isoprostane levels remain higher than in controls. This finding suggests that corticosteroids may not be fully effective in reducing oxidative stress in children with an exacerbation of asthma.
Keywords: asthma; exhaled breath condensate; children; cysteinyl leukotrienes; 8-isoprostane
This article has been cited by other articles:
![]() |
R. Do, K. H. Bartlett, H. Dimich-Ward, W. Chu, and S. M. Kennedy Biomarkers of Airway Acidity and Oxidative Stress in Exhaled Breath Condensate from Grain Workers Am. J. Respir. Crit. Care Med., November 15, 2008; 178(10): 1048 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nadeem, A. Masood, and N. Siddiqui Review: Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options Therapeutic Advances in Respiratory Disease, August 1, 2008; 2(4): 215 - 235. [Abstract] [PDF] |
||||
![]() |
V. Seto, C. Hirota, S. Hirota, and L. J. Janssen E-Ring Isoprostanes Stimulate a Cl Conductance in Airway Epithelium via Prostaglandin E2-Selective Prostanoid Receptors Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 88 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Paredes, T. Tazzeo, and L. J. Janssen E-Ring Isoprostane Augments Cholinergic Neurotransmission in Bovine Trachealis via FP Prostanoid Receptors Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 739 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Montuschi Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 5 - 23. [Abstract] [PDF] |
||||
![]() |
I Avalos, C P Chung, A Oeser, G L Milne, J D Morrow, T Gebretsadik, A Shintani, C Yu, and C M Stein Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms Lupus, March 1, 2007; 16(3): 195 - 200. [Abstract] [PDF] |
||||
![]() |
C. Liu, T. Tazzeo, and L. J. Janssen Isoprostane-induced airway hyperresponsiveness is dependent on internal Ca2+ handling and Rho/ROCK signaling Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1177 - L1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C N A Palmer, B J Lipworth, S Lee, T Ismail, D F Macgregor, and S Mukhopadhyay Arginine-16 {beta}2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol Thorax, November 1, 2006; 61(11): 940 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Muller, F. Morini, S. Eaton, M. Peters, and A. Jaffe Safety and feasibility of exhaled breath condensate collection in ventilated infants and children Eur. Respir. J., September 1, 2006; 28(3): 479 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes Corticosteroid effects on cell signalling Eur. Respir. J., February 1, 2006; 27(2): 413 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. MacGregor, S. Ellis, J. Andrews, M. Imrie, A. Innes, A. P. Greening, and S. Cunningham Breath condensate ammonium is lower in children with chronic asthma Eur. Respir. J., August 1, 2005; 26(2): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes, I. M. Adcock, and K. Ito Histone acetylation and deacetylation: importance in inflammatory lung diseases Eur. Respir. J., March 1, 2005; 25(3): 552 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Wood, M. L. Garg, J. L. Simpson, T. A. Mori, K. D. Croft, P. A. B. Wark, and P. G. Gibson Induced Sputum 8-Isoprostane Concentrations in Inflammatory Airway Diseases Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 426 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Harrison and C C Andersen Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease? Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2005; 90(1): F6 - F10. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kharitonov and P. J. Barnes Effects of Corticosteroids on Noninvasive Biomarkers of Inflammation in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 191 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catalli and L. J. Janssen Augmentation of bovine airway smooth muscle responsiveness to carbachol, KCl, and histamine by the isoprostane 8-iso-PGE2 Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1035 - L1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Moloney, S. E. Mumby, R. Gajdocsi, J. H. Cranshaw, S. A. Kharitonov, G. J. Quinlan, and M. J. Griffiths Exhaled Breath Condensate Detects Markers of Pulmonary Inflammation after Cardiothoracic Surgery Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 64 - 69. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |